This is the authors' abstract. We don't add key points for this paper.
The in vitro inhibitory effects of sitafloxacin (DU-6859a) and its three stereoisomers on bacterial DNA gyrase from Escherichia coli, topoisomerase IV from Staphylococcus aureus, and topoisomerase II from human placenta were compared. No correlation was observed between the inhibitory activities of quinolones against bacterial type II topoisomerases and those against human topoisomerase II. Sitafloxacin showed the most potent inhibitory activities against bacterial type II topoisomerases and the lowest activity against human type II topoisomerase.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Akasaka et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: